- Acumen Powered by Robins Kaplan LLP®
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
June 17, 2024Emily Tremblay Named IP Rising Star by Euromoney in 2024 Women in Business Law Awards
-
June 17, 2024Three Robins Kaplan Partners Named BTI Client Service All-Stars
-
June 13, 2024Brendan Johnson Named South Dakota Trial Lawyer of The Year
-
June 27, 2024Sex Abuse Litigation
-
June 10-11, 20242024 Probate and Trust Law Section Conference
-
June 11, 2024FBA 2024 Federal Practice Seminar
-
June 2024Robins Kaplan Secures Landmark $7.75 Million Verdict in Aerosol Duster Misuse Case
-
June 2024To Seize or Not to Seize: Campus Protests and Police Uses of Force
-
June 2024Communicating Your Estate Plan: A Helpful Tool, Not a Fix-All
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
ANDA Approvals
New Drug Applications and 505(b)(2) Applications
Fourth Quarter
![GENERICally Speaking](/-/media/images/newsletters/generically-speaking-social-graphics/generic_390x160.png?la=en&h=160&w=390&la=en&hash=7C4F410F9639FA5CC4261D8C8A36AB07)
This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA.
Approval Date | Reference Listed Drug | Generic Drug Name | NDA Holder | ANDA Applicant |
---|---|---|---|---|
10/03/2022 | Clolar | Clofarabine | Sanofi | Eugia Pharma |
10/03/2022 | Briviact | Brivaracetam | UCB | Zydus |
10/04/2022 | Combigan | Brimonidine Tartrate / Timolol Maleate | AbbVie | Teva |
10/04/2022 | Valcyte | Valganciclovir HCl | Roche | Hetero Labs |
10/05/2022 | Corlanor | Ivabradine HCl | Amgen | Annora Pharma |
10/06/2022 | Lumigan 0.03% | Bimatoprost | Allergan | Eugia Pharma |
10/06/2022 | Vimovo | Naproxen / Esomeprazole Magnesium | Horizon | Ajanta |
10/06/2022 | Tegretol XR | Carbamazepine | Novartis | Novitium Pharma |
10/07/2022 | Solodyn ER | Minocycline HCl | Bausch | Sidmak Labs |
10/07/2022 | Abreva | Docosanol | Glaxo | Encube |
10/07/2022 | Keppra | Levetiracetam | UCB | MSN |
10/11/2022 | Ovcon 35 | ethinyl estradiol / norethindrone | Warner Chilcott | Aurobindo |
10/11/2022 | Vfend | Voriconazole | Pfizer | Mylan |
10/11/2022 | Velcade | Bortezomib | Sanofi | Waverley Pharma |
10/11/2022 | Namenda XR | Memantine HCl | AbbVie | Xiamen LP Pharm |
10/11/2022 | Zyflo CR | Zileuton | Mylan | Annora Pharma |
10/12/2022 | Adcirca | tadalafil | Eli Lilly | Teva |
10/12/2022 | Theophylline Extended-Release Tablets | Theophylline | Bausch | Teva |
10/13/2022 | Dilantin | Extended Phenytoin Sodium | Viatris | Unichem |
10/14/2022 | Calcium Gluconate | Calcium Gluconate | Fresenius Kabi | Nivagen Pharms |
10/17/2022 | Lasix | Furosemide | Validus | Graviti Pharms |
10/17/2022 | Cytotec | Misoprostol | Pfizer | Micro Labs |
10/18/2022 | Tecfidera | Dimethyl Fumarate | Biogen | Prinston |
10/18/2022 | Cyclophosphamide | Cyclophosphamide | Baxter | Xellia Pharms Aps |
10/18/2022 | Neptazane | Methazolamide | Lederle | Tagi |
10/18/2022 | Toprol XL | Metoprolol Succinate | AstraZeneca | Accord Healthcare |
10/19/2022 | Doxil | Doxorubicin HCl (Liposomal) | J&J | Celerity Pharms |
10/19/2022 | Isuprel | Isoproterenol HCl | Bausch | American Regent |
10/20/2022 | Paraflex | Chlorzoxazone | J&J | Corepharma |
10/20/2022 | Taxol | Paclitaxel | HQ Specialty Pharma | Alembic Pharms |
10/21/2022 | Minipress | Prazosin HCl | Pfizer | Appco |
10/21/2022 | Cuyposa | Glycopyrrolate | Merz | Amneal |
10/21/2022 | Toradol | Ketorolac Tromethamine | Roche | Atnahs Pharma |
10/21/2022 | Toradol | Ketorolac Tromethamine | Roche | Zydus |
10/24/2022 | Prolixin | Fluphenazine HCl | Bristol-Myers Squibb | Upsher Smith Labs |
10/24/2022 | Mycamine | Micafungin Sodium | Astellas | Zydus |
10/24/2022 | Zaroxolyn | Metolazone | Lannett | Renata |
10/24/2022 | Vibra-Tabs | Doxycycline Hyclate | Pfizer | Amneal |
10/25/2022 | Abilify | Aripiprazole | Bristol-Myers Squibb | Glasshouse Pharms |
10/25/2022 | Zaroxolyn | Metolazone | Lannett | Aace Pharms |
10/25/2022 | Ofirmev | Acetaminophen | Mallinckrodt | Zydus |
10/25/2022 | Daraprim | Pyrimethamine | Vyera | Aurobindo |
10/26/2022 | Jevtana Kit | Cabazitaxel | Sanofi | Accord Healthcare |
10/26/2022 | Cuyposa | Glycopyrrolate | Merz | Alembic Pharms |
10/26/2022 | Lexiscan | Regadenoson | Astellas | Eugia Pharma |
10/26/2022 | Banzel | Rufinamide | Eisai | Aurobindo |
10/26/2022 | Narcan | Naloxone HCl | Bristol-Myers Squibb | Accord Healthcare |
10/27/2022 | Florinef | Fludrocortisone Acetate | Casper | Hikma |
10/27/2022 | Abilify | Aripiprazole | Bristol-Myers Squibb | Rubicon |
10/28/2022 | Naproxen | Naproxen Sodium | Bionpharma | Hetero Labs |
10/28/2022 | Lupron | Leuprolide Acetate | AbbVie | Amneal |
10/28/2022 | Trimethoprim | Trimethoprim | Mayne | Novitium Pharma |
10/28/2022 | Apriso | Mesalamine | Valeant | Alembic Pharms |
10/31/2022 | Combigan | Brimonidine Tartrate / Timolol Maleate | AbbVie | Akorn |
10/31/2022 | Velcade | Bortezomib | Sanofi | Myla |
10/31/2022 | Zyvox | Linezolid | Pfizer | Hetero |
10/31/2022 | Cupric Chloride | Cupric Chloride | Pfizer | Exela Pharma |
11/01/2022 | Buphenyl | Sodium Phenylbutyrate | Horizon | Glenmark |
11/02/2022 | Kenalog-40 | Triamcinolone Acetonide | Apothecon | Mylan |
11/02/2022 | Toradol | Ketorolac Tromethamine | Roche | Alembic Pharms |
11/02/2022 | Phenergan | Promethazine HCl | Mylan | Annora Pharma |
11/03/2022 | Ammonia N 13 | Ammonia N 13 | Feinstein | Univ Alahama Birmingham |
11/03/2022 | Bloxiverz | Neostigmine Methylsulfate | Exela | Nivagen Pharms |
11/03/2022 | Cleocin T | Clindamycin Phosphate | Pfizer | Amneal |
11/03/2022 | Lipitor | Atorvastatin Calcium | Pfizer | Lepu Pharm |
11/04/2022 | Trileptal | Oxcarbazepine | Novartis | Bionpharma |
11/04/2022 | Atropine Sulfate | Atropine Sulfate | Hospira | Medefil |
11/04/2022 | Ziac | Bisoprolol Fumarate / Hydrochlorothiazide | Teva | Cadila |
11/04/2022 | Amicar | Aminocaproic Acid | Akorn | Annora Pharma |
11/07/2022 | Banzel | Rufinamide | Eisai | Glasshouse Pharms |
11/07/2022 | Narcan | Naloxone HCl | Bristol-Myers Squib | Baxter Healthcare |
11/07/2022 | Imdur | Isosorbide Mononitrate | Schering Plough | Aurobindo |
11/08/2022 | Halcion | Triazolam | Pfizer | Sandoz |
11/09/2022 | Nexavar | Sorafenib Tosylate | Bayer | Yabao Pharm |
11/09/2022 | Denavir | Penciclovir | Mylan | Teva |
11/09/2022 | Prozac | Fluoxetine HCl | Eli Lilly and Co | Novitium Pharma |
11/09/2022 | Mexitil | Mexiletine HCl | Boehringer-Ingelheim | Annora Pharma |
11/10/2022 | Dizac | Diazepam | Pharmacia and Upjohn | Fresenius Kabi |
11/10/2022 | Cyclophosphamide | Cyclophosphamide | Hikma | Alembic Pharms |
11/14/2022 | Firvanq Kit | Vancomycin HCl | Azurity | Alkem Labs |
11/14/2022 | Bystolic | Nebivolol HCl | AbbVie | Mankind Pharma |
11/15/2022 | Bactroban | Mupirocin | Glaxo | Amneal |
11/15/2022 | Cyanocobalamin | Cyanocobalamin | American Regent | Sagent |
11/15/2022 | Keppra | Levetiracetam | UCB | MSN |
11/15/2022 | Brovana | Arformoterol Tartrate | Sunovion | Mankind Pharma |
11/15/2022 | Prolixin | Fluphenazine HCl | Bristol-Myers Squibb | Sandoz |
11/15/2022 | Prozac | Fluoxetine HCl | Eli Lilly and Co | Aptapharma |
11/16/2022 | Durezol | Difluprednate | Novartis | Dr Reddy's Labs |
11/16/2022 | DDAVP | Desmopressin Acetate | Ferring | Gland Pharma |
11/17/2022 | Potassium Chloride | Potassium Chloride | Genus | Strides |
11/17/2022 | AmBisome | Amphotericin B | Astellas | Eugia Pharma |
11/17/2022 | Gadavist | Gadobutrol | Bayer | Hengrui Pharma |
11/17/2022 | Valcyte | Valganciclovir HCl | Hoffman LaRoche | Aurobindo |
11/18/2022 | Haldol | Haloperidol | Ortho McNeil | MSN |
11/18/2022 | Procardia XL | Nifedipine | Pfizer | Pharmadax |
11/18/2022 | Procardia XL | Nifedipine | Pfizer | Alembic Pharms |
11/21/2022 | Eryped | Erythromycin Ethylsuccinate | Azurity | Cadila Pharms |
11/22/2022 | Compazine | Prochlorperazine Edisylate | GlaxoSmithKline | Hikma |
11/22/2022 | Pepcid | Famotidine | Merck | Zydus |
11/22/2022 | Mitomycin | Mitomycin | Bristol-Myers Squib | Gland Pharma |
11/23/2022 | Ocuflox | Ofloxacin | AbbVie | Mankind Pharma |
11/23/2022 | Lipitor | Atorvastatin Calcium | Pfizer | Biocon Pharma |
11/25/2022 | Bloxiverz | Neostigmine Methysulfate | Exela | Avet Lifesciences |
11/25/2022 | Rozerem | Ramelteon | Takeda | Xiromed |
11/25/2022 | Perforomist | Formoterol Fumarate | Mylan | Aucta |
11/28/2022 | Qudexy XR | Topiramate | Upsher Smith Labs | Zydus |
11/28/2022 | Cuyposa | Glycopyrrolate | Merz | Aspen |
11/28/2022 | Compazine | Prochlorperazine Edisylate | GlaxoSmithKline | Amneal |
11/28/2022 | Actigall | Ursodiol | Teva | Aurobindo |
11/28/2022 | Effexor XR | Venlafaxine HCl | Wyeth | Unique |
11/28/2022 | Sinemet | Carbidopa / Levodopa | Organon | Aurobindo |
11/28/2022 | Bentyl | Dicyclomine HCl | Allergan | Corepharma |
11/28/2022 | Brovana | Arformoterol Tartrate | Lupin | Slayback |
11/29/2022 | Pennsaid 2% | Diclofenac Sodium | Horizon | Alembic Pharms |
11/30/2022 | Noxafil | Posaconazole | Merck | Actavis |
11/30/2022 | Trileptal | Oxcarbazepine | Novartis | Aucta |
12/01/2022 | Vivelle-Dot | Estradiol | Novartis | Zydus |
12/02/2022 | Benicar | Olmesartan Medoxomil | Cosette | Prinston |
12/02/2022 | Brevibloc | Esmolol HCl | Baxter | HQ Spcecialty Pharma |
12/02/2022 | Tegretol XR | Carbamazepine | Novartis | Riconpharma |
12/06/2022 | Viibryd | Vilazodone HCl | AbbVie | Invagen Pharms |
12/07/2022 | Vivimusta | Bendamustine HCl | Slayback | Dr Reddy's Labs |
12/07/2022 | Vivimusta | Bendamustine HCl | Slayback | Accord Healthcare |
12/07/2022 | Vibramycin | Doxycycline Hyclate | Pfizer | Par |
12/08/2022 | Rapaflo | Silodosin | AbbVie | Zydus |
12/08/2022 | Noxafil | Posaconazole | Merck | Hetero Labs |
12/08/2022 | Desonide | Desonide | Padagis | Alembic |
12/09/2022 | Lyrica | Pregabalin | Pfizer | Zydus |
12/09/2022 | Kenalog in Orabase | Triamcinolone Acetonide | Delcor | Quagen |
12/09/2022 | Carnitor | Levocarnitine | Leadiant | Novitium Pharma |
12/12/2022 | Hetlioz | Tasimelteon | Vanda | Teva |
12/12/2022 | Combigan | Brimonidine Tartrate / Timolol Maleate | AbbVie | Upsher Smith Labs |
12/13/2022 | Latuda | Lurasidone HCl | Sunovion | Alkem Labs |
12/13/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Hong Kong |
12/13/2022 | Perforomist | Formoterol Fumarate | Mylan | Slayback |
12/13/2022 | Brevibloc | Esmolol HCl | Baxter | Amneal |
12/14/2022 | Bentyl | Dicyclomine HCl | Allergan | Rubicon |
12/15/2022 | Nimbex | Cisatracurium Besylate | AbbVie | Piramal |
12/16/2022 | Cupric Sulfate | Cupric Sulfate | Abraxis | American Regent |
12/09/2022 | Carnitor | Levocarnitine | Leadiant | Novitium Pharma |
12/12/2022 | Hetlioz | Tasimelteon | Vanda | Teva |
12/12/2022 | Combigan | Brimonidine Tartrate / Timolol Maleate | AbbVie | Upsher Smith Labs |
12/13/2022 | Latuda | Lurasidone HCl | Sunovion | Alkem Labs |
12/13/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Hong Kong |
12/13/2022 | Perforomist | Formoterol Fumarate | Mylan | Slayback |
12/13/2022 | Brevibloc | Esmolol HCl | Baxter | Amneal |
12/14/2022 | Bentyl | Dicyclomine HCl | Allergan | Rubicon |
12/15/2022 | Nimbex | Cisatracurium Besylate | AbbVie | Piramal |
12/16/2022 | Cupric Sulfate | Cupric Sulfate | Abraxis | American Regent |
12/16/2022 | Cardene | Nicardipine HCl | Chiesi | Glenmark |
12/16/2022 | Lasix | Furosemide | Sanofi | Mankind Pharma |
12/20/2022 | Hetlioz | Tasimelteon | Vanda | Apotex |
12/20/2022 | Symmetrel | Amantadine HCl | Endo | Humanwell Puracap |
12/20/2022 | Briviact | Brivaracetam | UCB | Lupin |
12/21/2022 | Alphagan P | Brimonidine Tartrate | Allergan | Apotex |
12/21/2022 | Synthroid | Levothyroxine Sodium | AbbVie | Macleods |
12/21/2022 | Uptravi | Selexipag | Actelion | Zydus |
12/21/2022 | Nicorette | Nicotine Polacrilex | GlaxoSmithKline | Fertin Pharma |
12/21/2022 | Dobutrex | Dobutamine HCl | Eli Lilly and Co | Hainan Poly |
12/21/2022 | Lincocin | Lincomycin HCl | Pfizer | Hainan Poly |
12/22/2022 | Tecfidera | Dimethyl Fumarate | Biogen | Aurobindo |
12/22/2022 | Faslodex | Fulvestrant | AstraZeneca | Alembic Pharms |
12/22/2022 | Noxafil | Posaconazole | Merck | Amneal |
12/22/2022 | Arranon | Nelarabine | Novartis | Dr Reddy's Labs |
12/23/2022 | Ranexa | Ranolazine | Gilead | Aurobindo |
12/23/2022 | Revatio | Sildenafil Citrate | Viatris | Aurobindo |
12/23/2022 | CellCept | Mycophenolate Mofetil HCl | Roche | Steriscience |
12/23/2022 | Cubicin | Daptomycin | Merck | Aspiro |
12/27/2022 | Vesicare | Solifenacin Succinate | Astellas | Aurobindo |
12/27/2022 | BiCNU | Carmustine | Avet | Accord Healthcare |
12/27/2022 | Zinc Sulfate | Zinc Sulfate | Fresenius Kabi | Fresenius Kabi |
12/27/2022 | Bentyl | Dicyclomine HCl | Allergan | Twi |
12/28/2022 | Halcion | Triazolam | Pfizer | Zydus |
12/29/2022 | Keveyis | Dichlorphenamide | Torrent | Torrent |
12/30/2022 | Potassium Chloride | Potassium Chloride | Genus | Guardian Drug |
12/30/2022 | Vidaza | Azacitidine | Celgene | Eugia Pharma |
12/30/2022 | Minipress | Prazosin HCl | Pfizer | Mankind Pharma |
GENERICally Speaking Hatch Waxman Bulletin
GENERICally Speaking Hatch Waxman Bulletin
READ MORE Related Publications
First Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
March 25, 2024
Endo Ventures Unlimited Co. v. Nexus Pharms. Inc.
GENERICally Speaking Hatch Waxman Bulletin
March 22, 2024
Mallinckrodt plc v. Airgas Therapeutics LLC
GENERICally Speaking Hatch Waxman Bulletin
March 8, 2024
UCB, Inc. v. Mylan Techs. Inc.
GENERICally Speaking Hatch Waxman Bulletin
March 5, 2024
Genentech, Inc. v. Sandoz, Inc.
GENERICally Speaking Hatch Waxman Bulletin
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.